Bfsg LLC cut its position in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 4.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,095 shares of the medical research company’s stock after selling 300 shares during the quarter. […] Read this story
